Identification of Protective B-Cell Epitopes within the Novel Malaria Vaccine Candidate Plasmodium falciparum Schizont Egress Antigen 1. Nixon, C. E., Park, S., Pond-Tor, S., Raj, D., Lambert, L. E., Orr-Gonzalez, S., Barnafo, E. K., Rausch, K. M., Friedman, J. F., Fried, M., Duffy, P. E., & Kurtis, J. D. Clinical and Vaccine Immunology, 24(7):e00068–17, /cdli/24/7/e00068–17.atom, July, 2017. Number: 7![Identification of Protective B-Cell Epitopes within the Novel Malaria Vaccine Candidate Plasmodium falciparum Schizont Egress Antigen 1 [link]](https://bibbase.org/img/filetypes/link.svg "link")
Paper doi abstract bibtex 1 download Naturally acquired antibodies to Plasmodium falciparum schizont egress antigen 1 (PfSEA-1A) are associated with protection against severe malaria in children. Vaccination of mice with SEA-1A from Plasmodium berghei (PbSEA-1A) decreases parasitemia and prolongs survival following P. berghei ANKA challenge. To enhance the immunogenicity of PfSEA-1A, we identified five linear B-cell epitopes using peptide microarrays probed with antisera from nonhuman primates vaccinated with recombinant PfSEA-1A (rPfSEA-1A). We evaluated the relationship between epitope-specific antibody levels and protection from parasitemia in a longitudinal treatment-reinfection cohort in western Kenya. Antibodies to three epitopes were associated with 16 to 17% decreased parasitemia over an 18-week high transmission season. We are currently designing immunogens to enhance antibody responses to these three epitopes.
@article{nixon_identification_2017,
title = {Identification of {Protective} {B}-{Cell} {Epitopes} within the {Novel} {Malaria} {Vaccine} {Candidate} {Plasmodium} falciparum {Schizont} {Egress} {Antigen} 1},
volume = {24},
issn = {1556-6811, 1556-679X},
url = {http://cvi.asm.org/lookup/doi/10.1128/CVI.00068-17},
doi = {10.1128/CVI.00068-17},
abstract = {Naturally acquired antibodies to Plasmodium falciparum schizont egress antigen 1 (PfSEA-1A) are associated with protection against severe malaria in children. Vaccination of mice with SEA-1A from Plasmodium berghei (PbSEA-1A) decreases parasitemia and prolongs survival following P. berghei ANKA challenge. To enhance the immunogenicity of PfSEA-1A, we identified five linear B-cell epitopes using peptide microarrays probed with antisera from nonhuman primates vaccinated with recombinant PfSEA-1A (rPfSEA-1A). We evaluated the relationship between epitope-specific antibody levels and protection from parasitemia in a longitudinal treatment-reinfection cohort in western Kenya. Antibodies to three epitopes were associated with 16 to 17\% decreased parasitemia over an 18-week high transmission season. We are currently designing immunogens to enhance antibody responses to these three epitopes.},
language = {en},
number = {7},
urldate = {2019-11-28},
journal = {Clinical and Vaccine Immunology},
author = {Nixon, Christina E. and Park, Sangshin and Pond-Tor, Sunthorn and Raj, Dipak and Lambert, Lynn E. and Orr-Gonzalez, Sachy and Barnafo, Emma K. and Rausch, Kelly M. and Friedman, Jennifer F. and Fried, Michal and Duffy, Patrick E. and Kurtis, Jonathan D.},
editor = {Wilkins, Patricia P.},
month = jul,
year = {2017},
note = {Number: 7},
keywords = {Accessories, Application - Antibody Validation / Epitope Mapping, Application - Infectious Diseases, Application - Vaccine Development, Country - USA, Other Organisms, PEPperCHIP - Customized - Linear, PEPperMAP - Epitope Mapping - Linear, Sample Type - Serum},
pages = {e00068--17, /cdli/24/7/e00068--17.atom},
}
Downloads: 1
{"_id":"nAhmJjq8HpGSPFGam","bibbaseid":"nixon-park-pondtor-raj-lambert-orrgonzalez-barnafo-rausch-etal-identificationofprotectivebcellepitopeswithinthenovelmalariavaccinecandidateplasmodiumfalciparumschizontegressantigen1-2017","authorIDs":[],"author_short":["Nixon, C. E.","Park, S.","Pond-Tor, S.","Raj, D.","Lambert, L. E.","Orr-Gonzalez, S.","Barnafo, E. K.","Rausch, K. M.","Friedman, J. F.","Fried, M.","Duffy, P. E.","Kurtis, J. D."],"bibdata":{"bibtype":"article","type":"article","title":"Identification of Protective B-Cell Epitopes within the Novel Malaria Vaccine Candidate Plasmodium falciparum Schizont Egress Antigen 1","volume":"24","issn":"1556-6811, 1556-679X","url":"http://cvi.asm.org/lookup/doi/10.1128/CVI.00068-17","doi":"10.1128/CVI.00068-17","abstract":"Naturally acquired antibodies to Plasmodium falciparum schizont egress antigen 1 (PfSEA-1A) are associated with protection against severe malaria in children. Vaccination of mice with SEA-1A from Plasmodium berghei (PbSEA-1A) decreases parasitemia and prolongs survival following P. berghei ANKA challenge. To enhance the immunogenicity of PfSEA-1A, we identified five linear B-cell epitopes using peptide microarrays probed with antisera from nonhuman primates vaccinated with recombinant PfSEA-1A (rPfSEA-1A). We evaluated the relationship between epitope-specific antibody levels and protection from parasitemia in a longitudinal treatment-reinfection cohort in western Kenya. Antibodies to three epitopes were associated with 16 to 17% decreased parasitemia over an 18-week high transmission season. We are currently designing immunogens to enhance antibody responses to these three epitopes.","language":"en","number":"7","urldate":"2019-11-28","journal":"Clinical and Vaccine Immunology","author":[{"propositions":[],"lastnames":["Nixon"],"firstnames":["Christina","E."],"suffixes":[]},{"propositions":[],"lastnames":["Park"],"firstnames":["Sangshin"],"suffixes":[]},{"propositions":[],"lastnames":["Pond-Tor"],"firstnames":["Sunthorn"],"suffixes":[]},{"propositions":[],"lastnames":["Raj"],"firstnames":["Dipak"],"suffixes":[]},{"propositions":[],"lastnames":["Lambert"],"firstnames":["Lynn","E."],"suffixes":[]},{"propositions":[],"lastnames":["Orr-Gonzalez"],"firstnames":["Sachy"],"suffixes":[]},{"propositions":[],"lastnames":["Barnafo"],"firstnames":["Emma","K."],"suffixes":[]},{"propositions":[],"lastnames":["Rausch"],"firstnames":["Kelly","M."],"suffixes":[]},{"propositions":[],"lastnames":["Friedman"],"firstnames":["Jennifer","F."],"suffixes":[]},{"propositions":[],"lastnames":["Fried"],"firstnames":["Michal"],"suffixes":[]},{"propositions":[],"lastnames":["Duffy"],"firstnames":["Patrick","E."],"suffixes":[]},{"propositions":[],"lastnames":["Kurtis"],"firstnames":["Jonathan","D."],"suffixes":[]}],"editor":[{"propositions":[],"lastnames":["Wilkins"],"firstnames":["Patricia","P."],"suffixes":[]}],"month":"July","year":"2017","note":"Number: 7","keywords":"Accessories, Application - Antibody Validation / Epitope Mapping, Application - Infectious Diseases, Application - Vaccine Development, Country - USA, Other Organisms, PEPperCHIP - Customized - Linear, PEPperMAP - Epitope Mapping - Linear, Sample Type - Serum","pages":"e00068–17, /cdli/24/7/e00068–17.atom","bibtex":"@article{nixon_identification_2017,\n\ttitle = {Identification of {Protective} {B}-{Cell} {Epitopes} within the {Novel} {Malaria} {Vaccine} {Candidate} {Plasmodium} falciparum {Schizont} {Egress} {Antigen} 1},\n\tvolume = {24},\n\tissn = {1556-6811, 1556-679X},\n\turl = {http://cvi.asm.org/lookup/doi/10.1128/CVI.00068-17},\n\tdoi = {10.1128/CVI.00068-17},\n\tabstract = {Naturally acquired antibodies to Plasmodium falciparum schizont egress antigen 1 (PfSEA-1A) are associated with protection against severe malaria in children. Vaccination of mice with SEA-1A from Plasmodium berghei (PbSEA-1A) decreases parasitemia and prolongs survival following P. berghei ANKA challenge. To enhance the immunogenicity of PfSEA-1A, we identified five linear B-cell epitopes using peptide microarrays probed with antisera from nonhuman primates vaccinated with recombinant PfSEA-1A (rPfSEA-1A). We evaluated the relationship between epitope-specific antibody levels and protection from parasitemia in a longitudinal treatment-reinfection cohort in western Kenya. Antibodies to three epitopes were associated with 16 to 17\\% decreased parasitemia over an 18-week high transmission season. We are currently designing immunogens to enhance antibody responses to these three epitopes.},\n\tlanguage = {en},\n\tnumber = {7},\n\turldate = {2019-11-28},\n\tjournal = {Clinical and Vaccine Immunology},\n\tauthor = {Nixon, Christina E. and Park, Sangshin and Pond-Tor, Sunthorn and Raj, Dipak and Lambert, Lynn E. and Orr-Gonzalez, Sachy and Barnafo, Emma K. and Rausch, Kelly M. and Friedman, Jennifer F. and Fried, Michal and Duffy, Patrick E. and Kurtis, Jonathan D.},\n\teditor = {Wilkins, Patricia P.},\n\tmonth = jul,\n\tyear = {2017},\n\tnote = {Number: 7},\n\tkeywords = {Accessories, Application - Antibody Validation / Epitope Mapping, Application - Infectious Diseases, Application - Vaccine Development, Country - USA, Other Organisms, PEPperCHIP - Customized - Linear, PEPperMAP - Epitope Mapping - Linear, Sample Type - Serum},\n\tpages = {e00068--17, /cdli/24/7/e00068--17.atom},\n}\n\n","author_short":["Nixon, C. E.","Park, S.","Pond-Tor, S.","Raj, D.","Lambert, L. E.","Orr-Gonzalez, S.","Barnafo, E. K.","Rausch, K. M.","Friedman, J. F.","Fried, M.","Duffy, P. E.","Kurtis, J. D."],"editor_short":["Wilkins, P. P."],"key":"nixon_identification_2017","id":"nixon_identification_2017","bibbaseid":"nixon-park-pondtor-raj-lambert-orrgonzalez-barnafo-rausch-etal-identificationofprotectivebcellepitopeswithinthenovelmalariavaccinecandidateplasmodiumfalciparumschizontegressantigen1-2017","role":"author","urls":{"Paper":"http://cvi.asm.org/lookup/doi/10.1128/CVI.00068-17"},"keyword":["Accessories","Application - Antibody Validation / Epitope Mapping","Application - Infectious Diseases","Application - Vaccine Development","Country - USA","Other Organisms","PEPperCHIP - Customized - Linear","PEPperMAP - Epitope Mapping - Linear","Sample Type - Serum"],"metadata":{"authorlinks":{}},"downloads":1},"bibtype":"article","biburl":"https://bibbase.org/zotero/PEPperPAPER","creationDate":"2020-09-11T10:12:06.053Z","downloads":1,"keywords":["accessories","application - antibody validation / epitope mapping","application - infectious diseases","application - vaccine development","country - usa","other organisms","pepperchip - customized - linear","peppermap - epitope mapping - linear","sample type - serum"],"search_terms":["identification","protective","cell","epitopes","within","novel","malaria","vaccine","candidate","plasmodium","falciparum","schizont","egress","antigen","nixon","park","pond-tor","raj","lambert","orr-gonzalez","barnafo","rausch","friedman","fried","duffy","kurtis"],"title":"Identification of Protective B-Cell Epitopes within the Novel Malaria Vaccine Candidate Plasmodium falciparum Schizont Egress Antigen 1","year":2017,"dataSources":["uik5uKfH7ojkHRgZZ","SpW9DDZAb3MEcktZg","pcAnmugzhzarwnP3W","9uWGudyxZThtytFHj","idrrfXaW5AQj5dNMY"]}